|
|
Dr. Michael Lynch from Roche Diagnostics MSA provides an introduction to SP142 training tools Veeva MC-US-08607
Content Declaration
Keep for 90 Days COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from Roche Diagnostics MSA discusses SP263 immune cell scoring. This is part 3 of a 3 part series. Veeva TE-US-01059
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 2 of a 3 part series. Veeva TE-US-01057
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 1 of a 3 part series Veeva #TE-US-01058
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
The Roche Medical and Scientific Affairs team provide an overview of NTRK fusions, testing methods and algorithms with a focus on pan-TRK IHC assay using VENTANA pan-TRK (EPR17341) Assay Veeva…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
In this brief introductory video, Dr. Bharathi Vennapusa discusses the patient impact of NTRK fusion testing in solid tumors. She also provides an overview of NTRK educational videos. Veeva…
Content Declaration
Keep for 90 Days COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak from the Roche Diagnostics US Medical and Scientific Affairs team provides an overview of the new Ventana HER2 Dual ISH assay, comparison to the original assay and examples of…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Chris McGowin from Roche Diagnostics US Medical and Scientific Affairs team discusses complementary testing methods for SARS-CoV-2. Veeva #TE-US-01053
Content Declaration
Keep for 90 Days COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Jason Baron from Roche Diagnostics Medical and Scientific Affairs team provides a preview of a USCAP2021 on-demand workshop looking at artificial intelligence and clinical decision support. …
Content Declaration
Keep for 90 Days COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Roche Diagnostics US Medical and Scientific Affairs welcome to USCAP video
Content Declaration
Keep for 90 Days COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. Part 4 of a 4 part series. …
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part 3 of a 4 part series. Content…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2 of a 4 part series. Content…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
Dr. Linda Ahn from Roche Medical and Scientific Affairs team discusses the current standard of care in cervical cancer screening. Part 1 of a 4 part series. Content and approvals of any product…
Content Declaration
Keep for 3 Years Language (In English)
English
|